Table 2.
The risk of negative clinical outcomes for patients with low and high high-density lipoprotein cholesterol (HDL-C) level in the propensity-adjusted cohort.
Low HDL-C | High HDL-C | |||
---|---|---|---|---|
|
|
|||
HR (95% CI) | P | HR (95% CI) | P | |
Cardiovascular death and MI | 1.755 (1.274–2.417) | 0.001 | 0.562 (0.275–1.146) | 0.113 |
Cardiovascular death | 2.233 (1.465–3.404) | < 0.001 | 0.775 (0.359–1.675) | 0.517 |
Recurrent MI | 1.203 (0.725–1.996) | 0.474 | 0.192 (0.027–1.389) | 0.102 |
All-cause death | 1.486 (1.084–2.036) | 0.014 | 0.964 (0.556–1.673) | 0.897 |
MACE | 1.022 (0.877–1.190) | 0.65 | 0.915 (0.697–1.202) | 0.524 |
CI — confidence interval; HR — hazard ratio; MI — myocardial infarction; MACE — major adverse cardiac event